The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other ...

(THE CONVERSATION) Chronic pain affects hundreds of millions of people around the world. But the opioid crisis in North America led many health care providers to realize they relied too heavily on ...

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

New research reveals how CBD and THC interact with brain receptors, unlocking potential for safer cannabis-based treatments.

Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

The pooled prevalence of chronic painful neuropathy is 41.22 percent among individuals with chemotherapy-induced peripheral ...

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

Country music star Carly Pearce, 34, is sharing a health update after she was diagnosed with a heart condition called ...

Sudden temperature changes may also play a role. Rapid shifts can challenge the body’s ability to adapt, which might worsen ...

Despite advances, there remain gaps in the understanding of and personalized treatment for chronic pain in rheumatology, especially among women.

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill ...